David Peereboom Selected Research

terameprocol

4/2012

Phase I study of terameprocol in patients with recurrent high-grade glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Peereboom Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 01/2003
8	Glioma (Gliomas) 02/2022 - 01/2005
6	Brain Neoplasms (Brain Tumor) 02/2022 - 06/2002
5	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 04/2008
3	Neoplasm Metastasis (Metastasis) 05/2015 - 01/2005
2	Breast Neoplasms (Breast Cancer) 10/2013 - 08/2010
2	Lung Neoplasms (Lung Cancer) 10/2013 - 08/2010
2	Neutropenia 08/2010 - 01/2003
2	Oligodendroglioma 04/2009 - 02/2003
2	Prostatic Neoplasms (Prostate Cancer) 03/2005 - 01/2005
1	Acidosis 04/2012
1	Hypoxia (Hypoxemia) 04/2012
1	Hand-Foot Syndrome 08/2010
1	Anemia 08/2010
1	Cystitis 08/2010
1	Pneumonia (Pneumonitis) 08/2010
1	Hemorrhage 08/2008
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2008
1	Fatigue 11/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2006
1	Lymphoma (Lymphomas) 01/2005
1	Disease Progression 01/2005
1	Astrocytoma (Pilocytic Astrocytoma) 02/2003
1	Thrombocytopenia (Thrombopenia) 01/2003

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 02/2003
3	Docetaxel (Taxotere)FDA Link 08/2010 - 01/2003
2	Bevacizumab (Avastin)FDA Link 10/2020 - 08/2008
2	Pharmaceutical PreparationsIBA 10/2013 - 05/2013
2	CilengitideIBA 10/2013 - 11/2012
2	IntegrinsIBA 10/2013 - 11/2012
2	PlatinumIBA 01/2006 - 01/2005
2	Gemcitabine FDA Link 01/2006 - 01/2003
1	Vorinostat FDA Link 10/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	tandutinibIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	fms-Like Tyrosine Kinase 3IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	iniparibIBA 10/2015
1	ProdrugsIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	Biological ProductsIBA 11/2012
1	Excipients (Suspending Agents)IBA 04/2012
1	terameprocolIBA 04/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2010
1	EnzymesIBA 08/2008
1	cositecanIBA 08/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 04/2008
1	Celecoxib (Celebrex)FDA Link 04/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2008
1	Interferon-alpha2bIBA 11/2006
1	Estrogen ReceptorsIBA 11/2006
1	Tamoxifen FDA LinkGeneric 11/2006
1	Formaldehyde (Formol)FDA Link 04/2006
1	ParaffinIBA 04/2006
1	Thalidomide (Thalomid)FDA Link 03/2005
1	AndrogensIBA 03/2005
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2005
1	Hormones (Hormone)IBA 01/2005
1	Platinum Compounds (Compounds, Platinum)IBA 01/2005
1	satraplatin (JM 216)IBA 01/2005
1	ElementsIBA 02/2003
1	Sulfhydryl Compounds (Thiols)IBA 06/2002

Therapy/Procedure

8	Therapeutics 02/2022 - 01/2005
4	Drug Therapy (Chemotherapy) 08/2010 - 06/2002
3	Radiotherapy 10/2013 - 04/2009
1	Oral Administration 01/2017
1	Contraindications 08/2008
1	Drug Tapering 11/2006
1	Immunotherapy 01/2005